Key Financial Inc’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Hold
1,912
0.03% 331
2025
Q4
$163K Hold
1,912
0.03% 324
2025
Q3
$146K Hold
1,912
0.03% 339
2025
Q2
$150K Sell
1,912
-400
-17% -$29.8K 0.03% 320
2025
Q1
$168K Hold
2,312
0.04% 291
2024
Q4
$171K Hold
2,312
0.04% 271
2024
Q3
$153K Hold
2,312
0.03% 283
2024
Q2
$214K Hold
2,312
0.05% 236
2024
Q1
$221K Sell
2,312
-589
-20% -$49.5K 0.06% 220
2023
Q4
$221K Hold
2,901
0.06% 210
2023
Q3
$201K Hold
2,901
0.07% 201
2023
Q2
$274K Hold
2,901
0.09% 176
2023
Q1
$240K Hold
2,901
0.09% 176
2022
Q4
$240K Hold
2,901
0.11% 145
2022
Q3
$240K Hold
2,901
0.11% 146
2022
Q2
$283K Hold
2,901
0.15% 116
2022
Q1
$342K Hold
2,901
0.17% 112
2021
Q4
$376K Hold
2,901
0.19% 105
2021
Q3
$328K Buy
2,901
+18
+0.6% +$2.06K 0.19% 105
2021
Q2
$324K Hold
2,883
0.18% 107
2021
Q1
$241K Hold
2,883
0.16% 125
2020
Q4
$263K Hold
2,883
0.2% 95
2020
Q3
$230K Buy
+2,883
New +$225K 0.24% 99
2020
Q2
Sell
-2,883
Closed -$188K 260
2020
Q1
$188K Hold
2,883
0.19% 94
2019
Q4
$224K Buy
+2,883
New +$225K 0.21% 100

Other funds holding EW

Key Financial Inc's EW Position: Q1 2026 in Review

Key Financial Inc held its Edwards Lifesciences (EW) position steady in Q1 2026 at 1,912 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #331.

Key Financial Inc first reported a position in EW in Q4 2019 and has held it in 25 quarters since. The position peaked at $376K in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Key Financial Inc held 1,912 shares of Edwards Lifesciences worth $153K as of Q1 2026.
  • Key Financial Inc left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.03% of Key Financial Inc's portfolio in Q1 2026, its #331 holding.
  • Key Financial Inc first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 25 quarters since.
  • Key Financial Inc's Edwards Lifesciences position peaked at $376K in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.